These results, along with a prior report demonstrating that a little-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like actions in mice,2 help the notion of targeting ACKR3 as a novel approach to modulate the opioid system, which could open new therapeutic avenues for opioid-related Ailments. Hello there. I just wished to https://brennusl505evl1.theobloggers.com/profile